➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Dow
Medtronic
AstraZeneca
McKesson
Baxter
Harvard Business School

Last Updated: May 14, 2021

DrugPatentWatch Database Preview

SERZONE Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

When do Serzone patents expire, and what generic alternatives are available?

Serzone is a drug marketed by Bristol Myers Squibb and is included in one NDA.

The generic ingredient in SERZONE is nefazodone hydrochloride. There are four drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the nefazodone hydrochloride profile page.

Drug patent expirations by year for SERZONE
Recent Clinical Trials for SERZONE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Boston Medical CenterPhase 2
Boston UniversityPhase 2

See all SERZONE clinical trials

Paragraph IV (Patent) Challenges for SERZONE
Tradename Dosage Ingredient NDA Submissiondate
SERZONE TABLET;ORAL nefazodone hydrochloride 020152

US Patents and Regulatory Information for SERZONE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bristol Myers Squibb SERZONE nefazodone hydrochloride TABLET;ORAL 020152-001 Dec 22, 1994 DISCN Yes No   Get Started for $10   Get Started for $10   Get Started for $10
Bristol Myers Squibb SERZONE nefazodone hydrochloride TABLET;ORAL 020152-004 Dec 22, 1994 DISCN Yes No   Get Started for $10   Get Started for $10   Get Started for $10
Bristol Myers Squibb SERZONE nefazodone hydrochloride TABLET;ORAL 020152-002 Dec 22, 1994 DISCN Yes No   Get Started for $10   Get Started for $10   Get Started for $10
Bristol Myers Squibb SERZONE nefazodone hydrochloride TABLET;ORAL 020152-003 Dec 22, 1994 DISCN Yes No   Get Started for $10   Get Started for $10   Get Started for $10
Bristol Myers Squibb SERZONE nefazodone hydrochloride TABLET;ORAL 020152-006 Dec 22, 1994 DISCN Yes No   Get Started for $10   Get Started for $10   Get Started for $10
Bristol Myers Squibb SERZONE nefazodone hydrochloride TABLET;ORAL 020152-005 Dec 22, 1994 DISCN Yes No   Get Started for $10   Get Started for $10   Get Started for $10
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for SERZONE

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Dow
Medtronic
Express Scripts
Boehringer Ingelheim
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.